BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Young PM, Peterson JJ, Calamia KT. Hypermetabolic activity in patients with active retroperitoneal fibrosis on F-18 FDG PET: report of three cases. Ann Nucl Med 2008;22:87-92. [DOI: 10.1007/s12149-007-0077-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Fernando A, Pattison J, Horsfield C, D’cruz D, Cook G, O’brien T. [ 18 F]-Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis, Treatment Stratification, and Monitoring of Patients with Retroperitoneal Fibrosis: A Prospective Clinical Study. European Urology 2017;71:926-33. [DOI: 10.1016/j.eururo.2016.10.046] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
2 Krishnan N, Perazella MA. The Role of PET Scanning in the Evaluation of Patients With Kidney Disease. Adv Chronic Kidney Dis 2017;24:154-61. [PMID: 28501078 DOI: 10.1053/j.ackd.2017.01.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
3 Jakhlal N, Elghazoui A, Jabbour Y, Karmouni T, Elkhader K, Koutani A, Ibenattya A. Fibrose rétropéritonéale: revue de littérature. Can Urol Assoc J 2017;11:E26-31. [PMID: 28163809 DOI: 10.5489/cuaj.4122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Ruhlmann V, Poeppel TD, Brandt AS, Grüneisen J, Ruhlmann M, Theysohn JM, Forsting M, Bockisch A, Umutlu L. (18)F-FDG PET/MRI evaluation of retroperitoneal fibrosis: a simultaneous multiparametric approach for diagnosing active disease. Eur J Nucl Med Mol Imaging 2016;43:1646-52. [PMID: 26969347 DOI: 10.1007/s00259-016-3351-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
5 Zhou HJ, Yan Y, Zhou B, Lan TF, Wang XY, Li CS. Retroperitoneal fibrosis: a retrospective clinical data analysis of 30 patients in a 10-year period. Chin Med J (Engl) 2015;128:804-10. [PMID: 25758277 DOI: 10.4103/0366-6999.152648] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
6 Pipitone N, Vaglio A, Salvarani C. Retroperitoneal fibrosis. Best Pract Res Clin Rheumatol 2012;26:439-48. [PMID: 23040359 DOI: 10.1016/j.berh.2012.07.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
7 Caiafa RO, Vinuesa AS, Izquierdo RS, Brufau BP, Ayuso Colella JR, Molina CN. Retroperitoneal Fibrosis: Role of Imaging in Diagnosis and Follow-up. RadioGraphics 2013;33:535-52. [DOI: 10.1148/rg.332125085] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 6.4] [Reference Citation Analysis]
8 Treglia G, Mattoli MV, Bertagna F, Giubbini R, Giordano A. Emerging role of Fluorine-18-fluorodeoxyglucose positron emission tomography in patients with retroperitoneal fibrosis: a systematic review. Rheumatol Int 2013;33:549-55. [PMID: 23124736 DOI: 10.1007/s00296-012-2576-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
9 Yilmaz S, Tan Y, Ozhan M, Halac M, Asa S, Sönmezoglu K. FDG PET/CT in monitoring treatment of retroperitoneal fibrosis. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2012;31:338-9. [DOI: 10.1016/j.remnie.2012.10.004] [Reference Citation Analysis]
10 Treglia G, Mattoli MV, Bertagna F. Fluorine-18-fluorodeoxyglucose positron emission tomography in assessing retroperitoneal fibrosis: a literature review. Int J Mol Imaging 2012;2012:484052. [PMID: 23050140 DOI: 10.1155/2012/484052] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Moroni G, Castellani M, Balzani A, Dore R, Bonelli N, Longhi S, Martinelli I, Messa P, Gerundini P. The value of (18)F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis. Eur J Nucl Med Mol Imaging 2012;39:1635-42. [PMID: 22801728 DOI: 10.1007/s00259-012-2144-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
12 Yilmaz S, Tan YZ, Ozhan M, Halac M, Asa S, Sönmezoglu K. FDG PET/CT in monitoring treatment of retroperitoneal fibrosis. Rev Esp Med Nucl Imagen Mol 2012;31:338-9. [PMID: 23084017 DOI: 10.1016/j.remn.2012.04.001] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
13 Mehta A, Blodgett TM. Retroperitoneal fibrosis as a cause of positive FDG PET/CT. J Radiol Case Rep 2011;5:35-41. [PMID: 22470805 DOI: 10.3941/jrcr.v5i7.722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
14 Sinapi I, Caers J, Connerotte T, Koutaissoff S, Lambert M. [Retroperitoneal fibrosis and multiple myeloma: fortuitous association?]. Rev Med Interne 2010;31:e4-6. [PMID: 20359790 DOI: 10.1016/j.revmed.2009.04.011] [Reference Citation Analysis]
15 Jansen I, Hendriksz TR, Han SH, Huiskes AW, van Bommel EF. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Eur J Intern Med. 2010;21:216-221. [PMID: 20493425 DOI: 10.1016/j.ejim.2010.02.008] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
16 Van Moerkercke W, Verhamme M, Meeus G, Oyen R, Steenbergen WV. A case of IgG4-related sclerosing disease with retroperitoneal fibrosis, autoimmune pancreatitis and bilateral focal nephritis. Pancreas 2009;38:825-32. [PMID: 19893455 DOI: 10.1097/MPA.0b013e318ac522f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Piccoli GB, Consiglio V, Arena V, Pelosi E, Anastasios D, Ragni F, Fiori C, Cortese G, Deagostini MC, Porpiglia F, Scarpa RM. Positron emission tomography as a tool for the 'tailored' management of retroperitoneal fibrosis: a nephro-urological experience. Nephrol Dial Transplant 2010;25:2603-10. [PMID: 20157170 DOI: 10.1093/ndt/gfq051] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
18 Swartz RD. Idiopathic Retroperitoneal Fibrosis: A Review of the Pathogenesis and Approaches to Treatment. American Journal of Kidney Diseases 2009;54:546-53. [DOI: 10.1053/j.ajkd.2009.04.019] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
19 Cheng YM, Ho CL, Chiu NT, Hsu KF. Cesarean section scar mimicking uterine malignant neoplasm at positron emission tomography/computed tomography. J Minim Invasive Gynecol 2009;16:372-4. [PMID: 19423072 DOI: 10.1016/j.jmig.2009.02.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]